MedPath

Assessment and Prevention of Caregiver Burden in Oncology

Not Applicable
Not yet recruiting
Conditions
Oncology
Caregiver Burden
Interventions
Other: Specific nursing support
Other: Non-specific nursing support
Registration Number
NCT05750836
Lead Sponsor
Institut Cancerologie de l'Ouest
Brief Summary

The goal of this randomized, open and controlled supportive care study is to see if we can reduce the burden on the caregiver by offering the caregiver systematic and regular support from the nurse (APN, nurse coordinator in French health care organisations) compared to a support focused on the patient. At the same time, we will also evaluate the impact of this personalised support for the caregiver on their anxiety and quality of life.

Participants will caregivers of a patient who started a line (any line) of systemic treatment for a solid tumour since less than 3 months or in an active palliative situation since less than 1 month.

Researchers will compare 2 groups : a group where caregivers benefit from specific nursing support and a group of caregivers with no specific nursing support.

The specific support includes 3 mandatory on-site nursing consultations with the patient's caregiver and interviews once a month with a nurse either by phone, on-site consultation or teleconsultation.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Caregiver designated by the patient;
  • Caregiver of a patient who started a line (any line) of systemic treatment for a solid tumour since less than 3 months or in an active palliative situation since less than 1 month;
  • Caregiver of patient already cared for by a nurse before inclusion or going to start a nursing follow-up;
  • Caregiver of a patient with a score ≥2 of social fragility and/or psychological fragility and/or nutritional fragility and/or complexity;
Exclusion Criteria
  • Patient whose life expectancy is assumed to be < 6 months;
  • Patient living in an institution (EHPAD, MAS, SSR, MCO, USLD) at inclusion;
  • Caregiver declared as having a pathology that could alter his/her capacity to support (psychiatric history, dementia...) or under guardianship.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Specific nursing supportSpecific nursing supportThe caregivers benefit from specific nursing support.
No specific nursing supportNon-specific nursing supportCaregivers do not receive any specific support from the nurses.
Primary Outcome Measures
NameTimeMethod
Caregiver burdenat 6 months post-randomisation

Comparison in the 2 groups. Burden score is assessed using the ZARIT SCALE. The test consists of 22 questions that the caregiver has to score from 0 to 4, the whole giving a score from 0 to 88. 0 means no burden, 88 means that the burden is severe

Secondary Outcome Measures
NameTimeMethod
Caregiver's quality of lifeat month 6 (M6) and month 12 (M12) post-randomisation.

Comparison in the 2 groups. The generic self-questionnaire SF36 consists of 36 items concerning the last four weeks before the test and divided into 8 dimensions (Physical activity ; Life and relationships with others ; Physical pain; Perceived health ; Vitality; Limitations due to the psychological state; Limitations due to the physical state; Psychological health).

These eight dimensions are used to measure two summary scores of the quality of life of individuals: the physical composite score (PCS) and the mental composite score (MCS). (score from 0 to 100).

A low score reflects a perception of poor health, loss of function, presence of pain. A high score reflects a perception of good health, absence of functional deficit and pain.

Caregiver's satisfactionat month 6 (M6) and month 12 (M12) post-randomisation.

Only arm B. P-GIC questionnaire consists of a single question asking the caregiver about their overall impression of change in specific support care. The caregiver is given the following 8 options and asked to indicate which of these best describes the perceived change: I don't know, Very strongly positive, Strongly positive, Slightly positive, No change, Slightly negative, Strongly negative, Very strongly negative.

The level of anxiety/depression of the caregiverat month 6 (M6) and month 12 (M12) post-randomisation.

Comparaison in the 2 groups.

Hospital Anxiety and Depression scale consists of 14 items to which participants respond on a 4-point Likert scale. Seven items assess anxiety and seven items assess depression. Anxiety and depression scores can range from 0 (no symptoms) to 21 (significant presence of symptoms). Threshold scores were determined as follows:

* between 0 and 7 : no symptoms of anxiety or depression;

* between 8 and 10 : some moderate symptoms (mild anxiety or depression);

* score of 11 or more : significant number of symptoms (severe anxiety or depression).

Trial Locations

Locations (5)

CH Cholet

🇫🇷

Cholet, France

Centre Antoine Lacassagne

🇫🇷

Nice, France

Centre Henri Bequerel

🇫🇷

Rouen, France

Institut de Cancérologie de l'Ouest

🇫🇷

Saint Herblain, France

CH Mémorial de Saint Lo

🇫🇷

Saint Lo, France

© Copyright 2025. All Rights Reserved by MedPath